.

Octanate

Human coagulation factor VIII

 

  • Composition
    Each vial with lyophilized powder contains the following active pharmaceutical ingredient:
    Octanate 250 U.I.: 250 IU of Human coagulation factor VIII.
    Octanate 500 U.I.: 500 IU of Human coagulation factor VIII.
    Octanate 1000 U.I.: 1000 IU of Human coagulation factor VIII.


  • Indications
    Treatment and prophylaxis of bleeding in patients with:
    - Haemophilia A (congenital deficiency of factor VIII).
    - Acquired factor VIII deficiency.
    - Treatment of haemophiliacs with antibodies to Factor VIII (inhibitors).

  • Contraindications
    Known hypersensitivity to the components of the product.

  • Presentation
    Octanate 250 U.I.:
    box containing one vial with lyophilized powder + one vial with 5 mL of solvent + the injection kit.
    Octanate 500 U.I.:
    box containing one vial with lyophilized powder + one vial with 10 mL of solvent + the injection kit.
    Octanate 1000 U.I.:
    box containing one vial with lyophilized powder + one vial with 10 mL of solvent + the injection kit.